BRUKER CORP (BRKR) Form 8-K — Aug 4, 2026
Bruker reported second quarter 2026 revenue of $838.5 million, an increase of 5.2% year-over-year, with organic growth of 2.8%. Despite the top-line growth, the company recorded a non-cash goodwill impairment charge of $134.9 million, resulting in a GAAP diluted loss per share of $(0.41). Adjusted for this charge and other items, non-GAAP EPS was $0.49, a significant improvement from $0.32 in the prior year. The Scientific Instruments segment demonstrated strength with organic bookings up 10% year-over-year, driven by demand in semiconductor tools and biopharma markets.
Key figures
- Revenue
- 838500000
- Revenue Yoy
- 5.2%
- Cash Position
- 184900000
- Non Gaap EPS
- 0.49
- Goodwill Impairment
- 134900000
- Organic Revenue Growth
- 2.8%
Price after filing
Close on the filing date to close N calendar days later (from $64.34). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.